Stock Analiz

Royalty Pharma plc (RPRX) dividend: yield, history and safety

Price $69.31 · data as of November 13, 2026

Dividend at a glance

Dividend yield1.36%
Annual dividend (est.)$0.94
5-year growth per year+17.5%
Payout ratio (EPS)38%
FCF covers dividend—
Years paid (our data)6

Dividend safety: weak

Royalty Pharma passes 2 of 5 checks.

  • Free cash flow covers the dividend
  • Pays out less than 75% of earnings
  • Dividend raised in most of the last 5 years
  • Debt under 3 years of free cash flow
  • Paid for at least 10 years in a row

Dividend history

Fiscal yearDividend per shareChangeTotal paidPayout ratio
2025$0.67+5.8%$378M38%
2024$0.63+6.6%$376M33%
2023$0.59−21.9%$358M23%
2022$0.76+10.7%$333M761%
2021$0.69+129.5%$285M46%
2020$0.30—$112M23%

From Royalty Pharma’s annual reports to the SEC; per-share figures adjusted for stock splits. Raised in 4 of the last 5 years.

Frequently asked questions

What is Royalty Pharma’s dividend yield?

About 1.36% at the current price of $69.31, or roughly $0.94 per share a year.

Is Royalty Pharma’s dividend safe?

Royalty Pharma passes 2 of our 5 dividend safety checks (weak).

How fast does Royalty Pharma raise its dividend?

The dividend per share grew about 17.5% a year over the last 5 years.

Built from SEC filings and market prices, rebuilt daily. Not investment advice. See the best dividend stocks